The department of states foia annual report for fy 2014 reported that the number of cases pending at the end of the fiscal year for state was 10,974. Over the past few years we have been focused on a broad scientific pipelinebuilding of innovative therapeutics by. Coms plc, tissue therapies limited, benitec biopharma limited. As a result of our data reconciliation and validation efforts, we have determined that the number. Benitec is in the midst of a phase iiia clinical trial for the companys lead compound, tt034 a treatment that has the potential to cure hepatitis c with a single injection. Benitec biopharma ltdadr bntc sec filing 20f annual report. Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Benitec biopharmas total inventories for the quarter that ended in dec. Interim report for the half year ended december 31, 2015.
Chairmans and ceos letter dear shareholder we are pleased to present benitec biopharmas annual report for the 2017 financial year. Directors the following persons were directors of benitec biopharma limited benitec during the whole of the period and. In 2015, ibi group experienced the first full year under our new strategic plan and we exceeded. Names of member banks as on march 31, 2016 are listed in annex i. Financial summary target 2015 annual report 2015 2014 20 2012 a 2011 financial results. Parent entity information continued guarantees entered into by the parent entity in relation to the debts of its subsidiaries the parent entity had no guarantees in relation to the debts of its subsidiaries as at 30 june 2016 and 30 june 2015. Directors the names of the directors in office during or since the end of the financial year and up to the date of this report are.
Directors meetings the company held sixteen directors meetings during the year. Hcl technologies is a leading global it services company operating out of 32 countries and with consolidated revenues of us. Click the button below to request a report when hardcopies become available. General information the financial statements cover benitec biopharma limited as a group consisting of benitec biopharma limited and the entities it controlled at the end of, or during, th year. The now, the new, and the next looking forward, the longterm outlook for our industry. The present report, together with the supplementary report on the availability of internationally. Benitec biopharma limited 6k oct 22 2015 seeking alpha. The following pdf files are available metro group annual report 2016 pdf 320 pages 7 mb to our shareholders pdf 18 pages 649 kb corporate. Latest companies and documents filed with the security and exchange commission. As a result of our data reconciliation and validation efforts, we have determined that the number should have been.
We have delivered 300,000 public company reports to over 27,000 individuals, from over 9,000 investment firms and to. Banking codes and standards board of india annual report 2015 16 2 membership fees for the year 2015 16. To be the preferred supplier of electricity and related services in the region by 2030. The net asset value per unit of your fund appreciated by 6. S our mission is to shape lifelong achievers who can speak and think in multiple languages and who can apply their knowledge anywhere in the world. The department of states foia annual report for fy 2014 reported that the number of appeals pending at the end of the fiscal year for state was 270. Directors the following persons were directors of benitec biopharma limited benitec during the whole of. Click the button below to be notified when financial info becomes available. The information in this report should be read in conjunction with the most recent annual financial report and any public announcements made by benitec biopharma limited.
Information about the directors the names and particulars of the directors of the during or since the end of the financial yeargroup are. Our production is sufficient to underpin around a third of current power generation in nigeria. Benitec biopharmas abstract accepted for presentation at the. Takkt ag annual financial statements 2019 in german. Benitec biopharma limited interim report for the halfyear ended december 31, 2018 which forms part of this asx announcement.
This has been a year of transition and substantial change for benitec. Factor therapeutics limited annual report 2016 ceo search active and ongoing we have continued our search for a ceo and although we have evaluated several promising candidates, we have yet to find the right individual for the company at this transition stage. The companys lead development candidate is gdc0084. Publications investor relations washtec car wash systems. Benitec biopharma limited page 2 interim report for the half year ended december 31, 2015 2. Analyze up to 10 years of full 10k annual reports and quarterly 10q sec filings for benitec biopharma ltdadr bntc using our online tools. Since the annual report 2015, the following improvements have been made. Oct 30, 2019 benitec biopharma ltdadr bntc sec filing 20f annual report for the fiscal year ending sunday, june 30, 2019. Incitec pivot limited has reached its limit for free report views. Blt is an australian biotechnology company founded in 1997. Benitec biopharma limited annual report 201415 3 chairmans and ceos letter dear shareholder we are pleased to present benitec biopharmas annual report for 2015. It is calculated as cost of goods sold divided by total inventories. This annual report presents the highlights of the 2015 16 year in the context of b3s achievements and outcomes from each of the five research themes, alon g with its critical objective areas.
Pdf incitec pivot limited does not currently have any hardcopy reports on. Annual report 2016 page 4 directors report the board of directors of optiscan imaging limited has pleasure in submitting its report in respect of the financial year ended 30 june 2016. Oceania australia biotechnology 27 october 2015 1 news and commentary australian life scientist antibody technology as a cancer imaging agent 23102015 the agreement is a key milestone for the company as it prepares to further exploit the potential of its antibody. We have transformed the company from being a patent and licensing focused.
Blt is pleased to announce that clinical data on its phase iiia study of tt034 for hepatitis c. Interim report for the half year ended december 31, 2015 read this article along with other careers information, tips and advice on biospace. The incb annual report for 2015together with the annual report on precursor chemicals1 and the special report on the availability of internationally controlled drugs2is published at a critical juncture in international cooperation in drug control, just weeks before the special session of. Your company has had another transformational year as we continue to advance our strategy to commercialise dna directed rna interference ddrnai technology. Sunedison inc does not currently have any reports on. Benitec biopharma limited blt intelligent investor. In order to comply with the provisions of the corporations act 2001, the directors report as follows. Annual report 20152016 international school of boston. We are pleased to present benitec biopharmas annual report for 2015. Parties related to ian mann hold a combined total of 17,668,445 ordinary shares as at the date of this report 2015.
The incb annual report for 2015together with the annual report on precursor chemicals1 and the special report on the availability of internationally controlled drugs2is published at a critical juncture in international cooperation in drug control, just weeks before the special session of the united nations general. The industry is witnessing a shift from a linear to a nonlinear growth, and thus following a differentiated path. Benitec biopharmas abstract accepted for presentation at. The annual report of benitec biopharma limited for the year ended 30 june 2015 is attached. The present report, together with the supplementary report on the availability of. Report of the manager we have great pleasure in presenting the annual report and audited accounts of the ceybank surakum fund for the period 1st january 2015 to 31st december 2015. View differences made from one year to another to evaluate benitec biopharma ltdadrs financial trajectory sample 10k yearoveryear yoy comparison compare this 20f annual report to its predecessor by reading our highlights to see what text and tables were removed, added and changed by benitec biopharma ltdadr. Benitec biopharma limited 6k nov 2 2015 seeking alpha.
Company news publications washtec share events corporate governance contact faq annual reports. Benitec biopharmas cost of goods sold for the three months ended in dec. It is engaged in the development of genesilencing therapies for the treatment of chronic and lifethreatening diseases using dnadirected rna interference ddrnai technology. Revenue per share is the amount of revenue per outstanding share of the companys stock.
Benitec biopharma limited annual report 201415 3 chairmans and ceos letter dear shareholder we are pleased to present benitec biopharma s annual report for 2015. Pursuant to section 12 of article of the articles of agreement establishing the pacific islands development bank, and section of rticle ii of the anks bylaws, it is my pleasure to transmit, on behalf of the oard of directors, the pacific islands development. On 30 september 2015, the consolidated entity applied for the listing of options issued pursuant. Annual reports browse our annual reports, available in downloadable pdf format. Benitec biopharma level 14, 114 william st melbourne vic 3000 australia p. Browse our annual reports, available in downloadable pdf format. With our leading gene therapy capabilities and highly credentialed scientific and management team, we play an essential role in the scientific community by advancing novel treatment options for treating human diseases. Benitec biopharma limited page 52 annual report 20152016 note 24. The companys directors present their report on the consolidated entity consisting of benitec biopharma limited and the entities it controlled group for the nine months ended march 31, 2017. Directors report the directors of cynata therapeutics limited cynata or the company and its controlled entities the group submit herewith the annual report of the group for the financial year ended 30 june 2016. For the effect of fees on your cumulative returns, please see our report how fees can destroy your wealth. The financial statements are presented in australian dollars.